Nuance Pharma Limited Deal History & Licensing Activity
Nuance Pharma Limited is a life sciences. Over the past three years, Nuance Pharma Limited has been involved in 1 licensing and acquisition transaction, with a primary focus on Vaccines (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Vaccines
Focus Area
Infectious Disease
Nuance Pharma Limited Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Nuance Pharma Limited in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| MVA-BN RSV vaccine | Nuance Pharma | Vaccines | Unknown | license | Mar 2026 |
Nuance Pharma Limited Pipeline Focus
Therapeutic areas and modalities where Nuance Pharma Limited is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Nuance Pharma Limited Strategic Signals
Key indicators of Nuance Pharma Limited's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Nuance Pharma Limited's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
Vaccines Benchmarks
Upfront, milestone, and royalty benchmarks for vaccines deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Nuance Pharma Limited Licensing & Deal Activity
Nuance Pharma Limited is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Nuance Pharma Limited ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Nuance Pharma Limited include Infectious Disease (2 deals and trials). In terms of modality, Nuance Pharma Limited has shown particular interest in vaccines.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Nuance Pharma Limited and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Nuance Pharma Limited's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.